NFG
MRNA icon

Norris Financial Group’s Moderna MRNA Stock Holding History

Norris Financial Group’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-2,589
Closed -$267K – 75
2023
Q3 		$267K Buy
2,589
+12
+0.5% +$1.34K 0.19% 55
2023
Q2 		$313K Sell
2,577
-1,107
-30% -$148K 0.22% 52
2023
Q1 		$566K Buy
3,684
+1,138
+45% +$188K 0.41% 45
2022
Q4 		$457K Buy
+2,546
New +$416K 0.39% 45

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Norris Financial Group's MRNA Position: Q4 2023 in Review

Norris Financial Group sold out of Moderna (MRNA) in Q4 2023, closing a stake of 2,589 shares — an estimated $267K sold.

Norris Financial Group first reported a position in MRNA in Q4 2022 and held it in 4 quarters. The position peaked at $566K in Q1 2023. 884 funds tracked by Wall St. Rank hold MRNA as of Q4 2023.

  • Norris Financial Group reported no remaining Moderna position as of Q4 2023 after selling out during the quarter.
  • Norris Financial Group sold 2,589 Moderna shares in Q4 2023, an estimated $267K.
  • Norris Financial Group first reported a position in Moderna in Q4 2022 and held it in 4 quarters.
  • Norris Financial Group's Moderna position peaked at $566K in Q1 2023.
  • 884 funds tracked by Wall St. Rank held Moderna as of Q4 2023.

Based on Norris Financial Group's 13F filing for Q4 2023, filed 20 May 2026.